Detection of Epstein-Barr virus in metastatic lymph nodes of patients with nasopharyngeal carcinoma and a primary unknown carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 3, 2003, Pages 338-340

  Nakao, Kazunari ^a   Yuge, Tadashi ^a   Mochiki, Masato ^a   Nibu, Ken ichi ^b   Sugasawa, Masashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; IDIOPATHIC DISEASE; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; NASOPHARYNX CARCINOMA; VIRUS DETECTION;

EID: 0037337137     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.129.3.338     Document Type: Article

References (17)

1. Chan CS, Chen CJ, Thomas W, eds. Cancer Registry Annual Report, 1996. Taipei, Taiwan: Dept of Health, the Executive Yuan (DOH); 1999.
2. Neel HB III. Nasopharyngeal carcinoma: diagnosis, staging, and management. Oncology (Huntingt). 1992;6:87-95; discussion, 99-102.
3. Old LJ, Boyse EA, Oettgen HF, et al. Precipitating antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proc Natl Acad Sci U S A. 1966;56:1699-1704.
4. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer. 1976;17:1-7.
5. Fahraeus R, Fu HL, Ernberg I, et al. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer. 1988;42:329-338.
6. Weiss LM, Movahed LA, Butler AE, et al. Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in situ hybridization. Am J Surg Pathol. 1989;13:625-631.
7. Akao I, Sato Y, Mukai K, et al. Detection of Epstein-Barr virus DNA in formalinfixed paraffin-embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction and in situ hybridization. Laryngoscope. 1991;101:279-283.
8. Walter MA, Menarguez-Palanca J, Peiper SC. Epstein-Barr virus detection in neck metastases by polymerase chain reaction. Laryngoscope. 1992;102:481-485.
9. Feinmesser R, Feinmesser M, Freeman JL, Noyek AM, Livni N. Detection of occult nasopharyngeal primary tumours by means of in situ hybridization. J Laryngol Otol. 1992;106:345-348.
10. Dictor M, Siven M, Tennvall J, Rambech E. Determination of nonendemic nasopharyngeal carcinoma by in situ hybridization for Epstein-Barr virus EBER1 RNA: sensitivity and specificity in cervical node metastases. Laryngoscope. 1995; 105(4, pt 1):407-412.
11. Murono S, Yoshizaki T, Tanaka S, Takeshita H, Park C, Furukawa M. Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction. Laryngoscope. 1997;107:523-526.
12. Popat SR, Liavaag PG, Morton R, McIvor N, Irish JC, Freeman JL. Epstein Barr virus genome in nasopharyngeal carcinomas from New Zealand. Head Neck. 2000; 22:505-508.
13. Tsai ST, Jin YT, Su IJ. Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization: a correlation with WHO histologic subtypes. Cancer. 1996;77:231-236.
14. Lee WY, Hsiao JR, Jin YT, Tsai ST. Epstein-Barr virus detection in neck metastases by in-situ hybridization in fine-needle aspiration cytologic studies: an aid for differentiating the primary site. Head Neck. 2000;22:336-340.
15. Niedobitek G, Hansmann ML, Herbst H, et al. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol. 1991;165:17-24.
16. Chang YS, Tyan YS, Liu ST, Tsai MS, Pao CC. Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification. J Clin Microbiol. 1990;28:2398-2402.
17. Niedobitek G, Agathanggelou A, Barber P, Smallman LA, Jones EL, Young LS. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol. 1993;170:457-461.